HomeInsightsStock Comparison

Jagsonpal Pharmaceuticals Ltd vs Venmax Drugs Pharmaceuticals Ltd Stock Comparison

Jagsonpal Pharmaceuticals Ltd vs Venmax Drugs Pharmaceuticals Ltd Stock Comparison

Last Updated on: Aug 29, 2025

Key Highlights

  • The Latest Trading Price of Jagsonpal Pharmaceuticals Ltd is ₹ 234.15 as of 29 Aug 15:30.
  • The P/E Ratio of Jagsonpal Pharmaceuticals Ltd changed from 5.8 on March 2020 to 32.9 on March 2024 . This represents a CAGR of 41.50% over 5 yearsThe P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Jagsonpal Pharmaceuticals Ltd changed from ₹ 45.72 crore on March 2020 to ₹ 737.06 crore on March 2024 . This represents a CAGR of 74.37% over 5 yearsThe Market Cap of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Jagsonpal Pharmaceuticals Ltd for the Jun '25 is ₹ 78.44 crore as compare to the Mar '25 revenue of ₹ 61.33 crore. This represent the growth of 27.9% The revenue of Venmax Drugs & Pharmaceuticals Ltd for the Jun '25 is ₹ 1.21 crore as compare to the Mar '25 revenue of ₹ 1.36 crore. This represent the decline of -11.03%.
  • The ebitda of Jagsonpal Pharmaceuticals Ltd for the Jun '25 is ₹ 17.04 crore as compare to the Mar '25 ebitda of ₹ 11.27 crore. This represent the growth of 51.2% The ebitda of Venmax Drugs & Pharmaceuticals Ltd for the Jun '25 is ₹ 0.04 crore as compare to the Mar '25 ebitda of ₹ 0.78 crore. This represent the decline of -94.87%.
  • The net profit of Jagsonpal Pharmaceuticals Ltd changed from ₹ 7.48 crore to ₹ 10.8 crore over 9 quarters. This represents a CAGR of 17.73% The net profit of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 0.02 crore to ₹ 0.04 crore over 9 quarters. This represents a CAGR of 36.08% .
  • The Dividend Payout of Jagsonpal Pharmaceuticals Ltd changed from 16.65 % on March 2020 to 58.86 % on March 2024 . This represents a CAGR of 28.73% over 5 yearsThe Dividend Payout of Venmax Drugs & Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Jagsonpal Pharmaceuticals Ltd

  • Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
  • The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
  • Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
  • It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
  • In 1994, the company has also promoted Aresco Financial Services, a new financial company.

About Venmax Drugs & Pharmaceuticals Ltd

  • Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Limited Company under the name and style of 'Yenkay Medico Private Limited', on 28 September, 1998.
  • The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
  • It became a Public Limited Company on February 3, 1995 with 'Yenkey Drugs & Pharmaceuticals Limited'.
  • Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
  • Initially, the Company engaged in the business of pharmaceutical products, drug intermediaries & API's etc.

Jagsonpal Pharmaceuticals Ltd News Hub

News

Jagsonpal Pharmaceuticals allots 66,000 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 66,000 equity shares of Rs. 2/- each under JPL ESOP...

Read more

08 Aug 2025 18:25

News

Jagsonpal Pharmaceuticals AGM scheduled

Jagsonpal Pharmaceuticals announced that the 45th Annual General Meeting(AGM) of the compa...

Read more

28 Jul 2025 11:09

News

Jagsonpal Pharmaceuticals to announce Quarterly Result

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

23 Jul 2025 15:57

News

Jagsonpal Pharmaceuticals allots 53,000 equity shares under ESOP

Jagsonpal Pharmaceuticals has allotted 53,000 equity shares under ESOP on 11 June 2025. Wi...

Read more

11 Jun 2025 18:15

News

Board of Jagsonpal Pharmaceuticals recommends final dividend

Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meet...

Read more

07 May 2025 09:28

News

Jagsonpal Pharmaceuticals to announce Quarterly Result

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on ...

Read more

30 Apr 2025 10:51

Venmax Drugs & Pharmaceuticals Ltd News Hub

News

Venmax Drugs & Pharmaceuticals schedules board meeting

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compan...

Read more

25 Aug 2025 17:37

News

Venmax Drugs & Pharmaceuticals to conduct board meeting

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compan...

Read more

11 Aug 2025 10:03

News

Venmax Drugs & Pharmaceuticals to declare Quarterly Results

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compan...

Read more

16 Jul 2025 17:26

News

Venmax Drugs & Pharmaceuticals to table results

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compan...

Read more

02 May 2025 13:38

News

Venmax Drugs & Pharmaceuticals announces board meeting date

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Compan...

Read more

04 Feb 2025 16:35

News

Venmax Drugs & Pharmaceuticals to conduct EGM

Venmax Drugs & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of t...

Read more

13 Jan 2025 11:36

SWOT Analysis Of Venmax Drugs & Pharmaceuticals Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Jagsonpal Pharmaceuticals Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Venmax Drugs & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Jagsonpal Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Jagsonpal Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Jagsonpal Pharmaceuticals Ltd or Venmax Drugs & Pharmaceuticals Ltd?

Market cap of Jagsonpal Pharmaceuticals Ltd is 1,558 Cr while Market cap of Venmax Drugs & Pharmaceuticals Ltd is 16 Cr

What are the key factors driving the stock performance of Jagsonpal Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd?

The stock performance of Jagsonpal Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jagsonpal Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd?

As of August 29, 2025, the Jagsonpal Pharmaceuticals Ltd stock price is INR ₹234.15. On the other hand, Venmax Drugs & Pharmaceuticals Ltd stock price is INR ₹31.89.

How do dividend payouts of Jagsonpal Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Jagsonpal Pharmaceuticals Ltd and Venmax Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions